Global Bioengineered Protein Drugs Market Professional Survey Report 2018

Publisher Name :
Date: 16-Jan-2018
No. of pages: 118
Inquire Before Buying

This report studies Bioengineered Protein Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

- GlaxoSmithKline

- Johnson & Johnson

- Merck

- Novartis

- Sanofi

- Eli Lilly

- F. Hoffmann-La Roche

- Dr. Reddy's Laboratories

- Abbott Laboratories

- Amgen

- Bayer AG

- Biocon

- Fresenius kabi

- Panacea Biotec

- ProBioGen AG

- Reliance Life Science

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Monoclonal Antibodies

- Therapeutic Proteins

- Vaccines

By Application, the market can be split into

- Pharma and Biotech Companies

- CROs

- Academics

By Regions, this report covers (we can add the regions/countries as you want)

- North America

- China

- Europe

- Southeast Asia

- Japan

- India

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Bioengineered Protein Drugs Market Professional Survey Report 2018

Table of Contents
Global Bioengineered Protein Drugs Market Professional Survey Report 2018
1 Industry Overview of Bioengineered Protein Drugs
1.1 Definition and Specifications of Bioengineered Protein Drugs
1.1.1 Definition of Bioengineered Protein Drugs
1.1.2 Specifications of Bioengineered Protein Drugs
1.2 Classification of Bioengineered Protein Drugs
1.2.1 Monoclonal Antibodies
1.2.2 Therapeutic Proteins
1.2.3 Vaccines
1.3 Applications of Bioengineered Protein Drugs
1.3.1 Pharma and Biotech Companies
1.3.2 CROs
1.3.3 Academics
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs
2.3 Manufacturing Process Analysis of Bioengineered Protein Drugs
2.4 Industry Chain Structure of Bioengineered Protein Drugs
3 Technical Data and Manufacturing Plants Analysis of Bioengineered Protein Drugs
3.1 Capacity and Commercial Production Date of Global Bioengineered Protein Drugs Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Bioengineered Protein Drugs Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Bioengineered Protein Drugs Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Bioengineered Protein Drugs Major Manufacturers in 2016
4 Global Bioengineered Protein Drugs Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Bioengineered Protein Drugs Capacity and Growth Rate Analysis
4.2.2 2016 Bioengineered Protein Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Bioengineered Protein Drugs Sales and Growth Rate Analysis
4.3.2 2016 Bioengineered Protein Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Bioengineered Protein Drugs Sales Price
4.4.2 2016 Bioengineered Protein Drugs Sales Price Analysis (Company Segment)
5 Bioengineered Protein Drugs Regional Market Analysis
5.1 North America Bioengineered Protein Drugs Market Analysis
5.1.1 North America Bioengineered Protein Drugs Market Overview
5.1.2 North America 2012-2017E Bioengineered Protein Drugs Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Bioengineered Protein Drugs Sales Price Analysis
5.1.4 North America 2016 Bioengineered Protein Drugs Market Share Analysis
5.2 China Bioengineered Protein Drugs Market Analysis
5.2.1 China Bioengineered Protein Drugs Market Overview
5.2.2 China 2012-2017E Bioengineered Protein Drugs Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Bioengineered Protein Drugs Sales Price Analysis
5.2.4 China 2016 Bioengineered Protein Drugs Market Share Analysis
5.3 Europe Bioengineered Protein Drugs Market Analysis
5.3.1 Europe Bioengineered Protein Drugs Market Overview
5.3.2 Europe 2012-2017E Bioengineered Protein Drugs Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Bioengineered Protein Drugs Sales Price Analysis
5.3.4 Europe 2016 Bioengineered Protein Drugs Market Share Analysis
5.4 Southeast Asia Bioengineered Protein Drugs Market Analysis
5.4.1 Southeast Asia Bioengineered Protein Drugs Market Overview
5.4.2 Southeast Asia 2012-2017E Bioengineered Protein Drugs Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Bioengineered Protein Drugs Sales Price Analysis
5.4.4 Southeast Asia 2016 Bioengineered Protein Drugs Market Share Analysis
5.5 Japan Bioengineered Protein Drugs Market Analysis
5.5.1 Japan Bioengineered Protein Drugs Market Overview
5.5.2 Japan 2012-2017E Bioengineered Protein Drugs Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Bioengineered Protein Drugs Sales Price Analysis
5.5.4 Japan 2016 Bioengineered Protein Drugs Market Share Analysis
5.6 India Bioengineered Protein Drugs Market Analysis
5.6.1 India Bioengineered Protein Drugs Market Overview
5.6.2 India 2012-2017E Bioengineered Protein Drugs Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Bioengineered Protein Drugs Sales Price Analysis
5.6.4 India 2016 Bioengineered Protein Drugs Market Share Analysis
6 Global 2012-2017E Bioengineered Protein Drugs Segment Market Analysis (by Type)
6.1 Global 2012-2017E Bioengineered Protein Drugs Sales by Type
6.2 Different Types of Bioengineered Protein Drugs Product Interview Price Analysis
6.3 Different Types of Bioengineered Protein Drugs Product Driving Factors Analysis
6.3.1 Monoclonal Antibodies of Bioengineered Protein Drugs Growth Driving Factor Analysis
6.3.2 Therapeutic Proteins of Bioengineered Protein Drugs Growth Driving Factor Analysis
6.3.3 Vaccines of Bioengineered Protein Drugs Growth Driving Factor Analysis
7 Global 2012-2017E Bioengineered Protein Drugs Segment Market Analysis (by Application)
7.1 Global 2012-2017E Bioengineered Protein Drugs Consumption by Application
7.2 Different Application of Bioengineered Protein Drugs Product Interview Price Analysis
7.3 Different Application of Bioengineered Protein Drugs Product Driving Factors Analysis
7.3.1 Pharma and Biotech Companies of Bioengineered Protein Drugs Growth Driving Factor Analysis
7.3.2 CROs of Bioengineered Protein Drugs Growth Driving Factor Analysis
7.3.3 Academics of Bioengineered Protein Drugs Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Bioengineered Protein Drugs
8.1 GlaxoSmithKline
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 GlaxoSmithKline 2016 Bioengineered Protein Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 GlaxoSmithKline 2016 Bioengineered Protein Drugs Business Region Distribution Analysis
8.2 Johnson & Johnson
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Johnson & Johnson 2016 Bioengineered Protein Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Johnson & Johnson 2016 Bioengineered Protein Drugs Business Region Distribution Analysis
8.3 Merck
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Merck 2016 Bioengineered Protein Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Merck 2016 Bioengineered Protein Drugs Business Region Distribution Analysis
8.4 Novartis
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Novartis 2016 Bioengineered Protein Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Novartis 2016 Bioengineered Protein Drugs Business Region Distribution Analysis
8.5 Sanofi
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Sanofi 2016 Bioengineered Protein Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Sanofi 2016 Bioengineered Protein Drugs Business Region Distribution Analysis
8.6 Eli Lilly
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Eli Lilly 2016 Bioengineered Protein Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Eli Lilly 2016 Bioengineered Protein Drugs Business Region Distribution Analysis
8.7 F. Hoffmann-La Roche
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 F. Hoffmann-La Roche 2016 Bioengineered Protein Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 F. Hoffmann-La Roche 2016 Bioengineered Protein Drugs Business Region Distribution Analysis
8.8 Dr. Reddy's Laboratories
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Dr. Reddy's Laboratories 2016 Bioengineered Protein Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Dr. Reddy's Laboratories 2016 Bioengineered Protein Drugs Business Region Distribution Analysis
8.9 Abbott Laboratories
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Abbott Laboratories 2016 Bioengineered Protein Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Abbott Laboratories 2016 Bioengineered Protein Drugs Business Region Distribution Analysis
8.10 Amgen
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Amgen 2016 Bioengineered Protein Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Amgen 2016 Bioengineered Protein Drugs Business Region Distribution Analysis
8.11 Bayer AG
8.12 Biocon
8.13 Fresenius kabi
8.14 Panacea Biotec
8.15 ProBioGen AG
8.16 Reliance Life Science
9 Development Trend of Analysis of Bioengineered Protein Drugs Market
9.1 Global Bioengineered Protein Drugs Market Trend Analysis
9.1.1 Global 2017-2022 Bioengineered Protein Drugs Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Bioengineered Protein Drugs Sales Price Forecast
9.2 Bioengineered Protein Drugs Regional Market Trend
9.2.1 North America 2017-2022 Bioengineered Protein Drugs Consumption Forecast
9.2.2 China 2017-2022 Bioengineered Protein Drugs Consumption Forecast
9.2.3 Europe 2017-2022 Bioengineered Protein Drugs Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Bioengineered Protein Drugs Consumption Forecast
9.2.5 Japan 2017-2022 Bioengineered Protein Drugs Consumption Forecast
9.2.6 India 2017-2022 Bioengineered Protein Drugs Consumption Forecast
9.3 Bioengineered Protein Drugs Market Trend (Product Type)
9.4 Bioengineered Protein Drugs Market Trend (Application)
10 Bioengineered Protein Drugs Marketing Type Analysis
10.1 Bioengineered Protein Drugs Regional Marketing Type Analysis
10.2 Bioengineered Protein Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Bioengineered Protein Drugs by Region
10.4 Bioengineered Protein Drugs Supply Chain Analysis
11 Consumers Analysis of Bioengineered Protein Drugs
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Bioengineered Protein Drugs Market Professional Survey Report 2018
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Bioengineered Protein Drugs
Table Product Specifications of Bioengineered Protein Drugs
Table Classification of Bioengineered Protein Drugs
Figure Global Production Market Share of Bioengineered Protein Drugs by Type in 2016
Figure Monoclonal Antibodies Picture
Table Major Manufacturers of Monoclonal Antibodies
Figure Therapeutic Proteins Picture
Table Major Manufacturers of Therapeutic Proteins
Figure Vaccines Picture
Table Major Manufacturers of Vaccines
Table Applications of Bioengineered Protein Drugs
Figure Global Consumption Volume Market Share of Bioengineered Protein Drugs by Application in 2016
Figure Pharma and Biotech Companies Examples
Table Major Consumers in Pharma and Biotech Companies
Figure CROs Examples
Table Major Consumers in CROs
Figure Academics Examples
Table Major Consumers in Academics
Figure Market Share of Bioengineered Protein Drugs by Regions
Figure North America Bioengineered Protein Drugs Market Size (Million USD) (2012-2022)
Figure China Bioengineered Protein Drugs Market Size (Million USD) (2012-2022)
Figure Europe Bioengineered Protein Drugs Market Size (Million USD) (2012-2022)
Figure Southeast Asia Bioengineered Protein Drugs Market Size (Million USD) (2012-2022)
Figure Japan Bioengineered Protein Drugs Market Size (Million USD) (2012-2022)
Figure India Bioengineered Protein Drugs Market Size (Million USD) (2012-2022)
Table Bioengineered Protein Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs in 2016
Figure Manufacturing Process Analysis of Bioengineered Protein Drugs
Figure Industry Chain Structure of Bioengineered Protein Drugs
Table Capacity and Commercial Production Date of Global Bioengineered Protein Drugs Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Bioengineered Protein Drugs Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Bioengineered Protein Drugs Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Bioengineered Protein Drugs Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Bioengineered Protein Drugs 2012-2017
Figure Global 2012-2017E Bioengineered Protein Drugs Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Bioengineered Protein Drugs Market Size (Value) and Growth Rate
Table 2012-2017E Global Bioengineered Protein Drugs Capacity and Growth Rate
Table 2016 Global Bioengineered Protein Drugs Capacity (K Pcs) List (Company Segment)
Table 2012-2017E Global Bioengineered Protein Drugs Sales (K Pcs) and Growth Rate
Table 2016 Global Bioengineered Protein Drugs Sales (K Pcs) List (Company Segment)
Table 2012-2017E Global Bioengineered Protein Drugs Sales Price (USD/Pcs)
Table 2016 Global Bioengineered Protein Drugs Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Bioengineered Protein Drugs 2012-2017E
Figure North America 2012-2017E Bioengineered Protein Drugs Sales Price (USD/Pcs)
Figure North America 2016 Bioengineered Protein Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Bioengineered Protein Drugs 2012-2017E
Figure China 2012-2017E Bioengineered Protein Drugs Sales Price (USD/Pcs)
Figure China 2016 Bioengineered Protein Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Bioengineered Protein Drugs 2012-2017E
Figure Europe 2012-2017E Bioengineered Protein Drugs Sales Price (USD/Pcs)
Figure Europe 2016 Bioengineered Protein Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Bioengineered Protein Drugs 2012-2017E
Figure Southeast Asia 2012-2017E Bioengineered Protein Drugs Sales Price (USD/Pcs)
Figure Southeast Asia 2016 Bioengineered Protein Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Bioengineered Protein Drugs 2012-2017E
Figure Japan 2012-2017E Bioengineered Protein Drugs Sales Price (USD/Pcs)
Figure Japan 2016 Bioengineered Protein Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Bioengineered Protein Drugs 2012-2017E
Figure India 2012-2017E Bioengineered Protein Drugs Sales Price (USD/Pcs)
Figure India 2016 Bioengineered Protein Drugs Sales Market Share
Table Global 2012-2017E Bioengineered Protein Drugs Sales (K Pcs) by Type
Table Different Types Bioengineered Protein Drugs Product Interview Price
Table Global 2012-2017E Bioengineered Protein Drugs Sales (K Pcs) by Application
Table Different Application Bioengineered Protein Drugs Product Interview Price
Table GlaxoSmithKline Information List
Table Product A Overview
Table Product B Overview
Table 2016 GlaxoSmithKline Bioengineered Protein Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 GlaxoSmithKline Bioengineered Protein Drugs Business Region Distribution
Table Johnson & Johnson Information List
Table Product A Overview
Table Product B Overview
Table 2016 Johnson & Johnson Bioengineered Protein Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Johnson & Johnson Bioengineered Protein Drugs Business Region Distribution
Table Merck Information List
Table Product A Overview
Table Product B Overview
Table 2015 Merck Bioengineered Protein Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Merck Bioengineered Protein Drugs Business Region Distribution
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis Bioengineered Protein Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Novartis Bioengineered Protein Drugs Business Region Distribution
Table Sanofi Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sanofi Bioengineered Protein Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Sanofi Bioengineered Protein Drugs Business Region Distribution
Table Eli Lilly Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eli Lilly Bioengineered Protein Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Eli Lilly Bioengineered Protein Drugs Business Region Distribution
Table F. Hoffmann-La Roche Information List
Table Product A Overview
Table Product B Overview
Table 2016 F. Hoffmann-La Roche Bioengineered Protein Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 F. Hoffmann-La Roche Bioengineered Protein Drugs Business Region Distribution
Table Dr. Reddy's Laboratories Information List
Table Product A Overview
Table Product B Overview
Table 2016 Dr. Reddy's Laboratories Bioengineered Protein Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Dr. Reddy's Laboratories Bioengineered Protein Drugs Business Region Distribution
Table Abbott Laboratories Information List
Table Product A Overview
Table Product B Overview
Table 2016 Abbott Laboratories Bioengineered Protein Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Abbott Laboratories Bioengineered Protein Drugs Business Region Distribution
Table Amgen Information List
Table Product A Overview
Table Product B Overview
Table 2016 Amgen Bioengineered Protein Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Amgen Bioengineered Protein Drugs Business Region Distribution
Table Bayer AG Information List
Table Biocon Information List
Table Fresenius kabi Information List
Table Panacea Biotec Information List
Table ProBioGen AG Information List
Table Reliance Life Science Information List
Figure Global 2017-2022 Bioengineered Protein Drugs Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2017-2022 Bioengineered Protein Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Bioengineered Protein Drugs Sales Price (USD/Pcs) Forecast
Figure North America 2017-2022 Bioengineered Protein Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2017-2022 Bioengineered Protein Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2017-2022 Bioengineered Protein Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Bioengineered Protein Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2017-2022 Bioengineered Protein Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2017-2022 Bioengineered Protein Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Bioengineered Protein Drugs by Type 2017-2022
Table Global Consumption Volume (K Pcs) of Bioengineered Protein Drugs by Application 2017-2022
Table Traders or Distributors with Contact Information of Bioengineered Protein Drugs by Region
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Inosine Pranobex Market 2018, Forecast to 2023
    Published: 17-Aug-2018        Price: US 4880 Onwards        Pages: 133
    Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with int......
  • Global Inosine Pranobex Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Aug-2018        Price: US 3480 Onwards        Pages: 135
    Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with int......
  • Global and India Lactulose Market Research by Company, Type & Application 2013-2025
    Published: 16-Aug-2018        Price: US 2000 Onwards        Pages: 115
    Summary Lactulose a "bifidus factor" is composed of galactose and fructose, which can be produced by the isomerization of lactose. It is a prebiotic carbohydrate which stimulates the growth of health-promoting bacteria in the gastrointestinal tract, it can also be used for the treatment of constipation, hepatic encephalopathy, tumour prevention, and to maintain blood glucose and insulin level. Market Segment as follows: By Type - Crystalline Lactulose - Liquid......
  • Global and India Steroid-Corticosteroids Market Research by Company, Type & Application 2013-2025
    Published: 16-Aug-2018        Price: US 2000 Onwards        Pages: 107
    Summary Steroid-Corticosteroids are a class of steroid hormones that are produced in the adrenal cortex of vertebrates, as well as the synthetic analogues of these hormones. Market Segment as follows: By Type - Cream - Injection - Others By Application - Hospital - Clinic - Others By Company - Pfizer - Sumitomo - Novartis - Merck - Sanofi - Johnson and Johnson - GSK......
  • Global and India Inhalation & Nasal Spray Generic Drugs Market Research by Company, Type & Application 2013-2025
    Published: 16-Aug-2018        Price: US 2000 Onwards        Pages: 108
    Summary Generic drugs are drugs that are not associated with any company or a brand name and are subject to regulation of countries where they are dispensed. According to US FDA, A generic drug is identical--or bioequivalent--to a brand name drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.Inhalation & Nasal Spray is a kind of drug used to relieve sneezing, runny, stuffy, or itchy nose and itchy, watery eyes caused by ha......
  • Global DNA Vaccines Market Professional Survey Report 2018
    Published: 16-Aug-2018        Price: US 3500 Onwards        Pages: 107
    This report studies the global DNA Vaccines market status and forecast, categorizes the global DNA Vaccines market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). A DNA vaccine is a small, circular DNA plasmid that encode one or more protein antigens under the control of a promoter t......
  • 2018-2023 Global Varicella Attenuated Live Vaccine Consumption Market Report
    Published: 16-Aug-2018        Price: US 4660 Onwards        Pages: 137
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Varicella Attenuated Live Vaccine market for 2018-2023. A live attenuated varicella vaccine, derived from the Oka strain of VZV has clinical efficacy for the prevention of varicella. The downstream industries of varicella attenuated live vaccine products are kids and adults. In the recent years, with the recovery of global economic, the development o......
  • 2018-2023 Global PVP Iodine Consumption Market Report
    Published: 16-Aug-2018        Price: US 4660 Onwards        Pages: 163
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global PVP Iodine market for 2018-2023. Povidone-Iodine is a stable chemical complex of Polyvinylpyrrolidone (Povidone, PVP) and elemental Iodine (I). It contains from 9.0% to 12.0% available iodine. And base on the output of the PVP Iodines, the classification of PVP Iodine includes Medical Grade, Industrial Grade, and the proportion of Medical Grade in 20......
  • 2018-2023 Global Zika Virus Testing Consumption Market Report
    Published: 16-Aug-2018        Price: US 4660 Onwards        Pages: 159
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Zika Virus Testing market for 2018-2023. Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosqu......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs